Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Coherus BioSciences, Inc.”

73 pharma patents match "Coherus BioSciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 73
Index total 30,257
Page 3 / 4

Quick answer

This filtered view shows 73 pharmaceutical patents matching "Coherus BioSciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

73 results for “Coherus BioSciences, Inc.” · 30,257 patents in full index Clear search

  1. US 9943601

    Etanercept formulations stabilized with combinations of sugars and polyols

    Coherus BioSciences, Inc. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted
  2. US 9861695

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  3. US 9808525

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  4. US 9801942

    Etanercept formulations stabilized with metal ions

    Coherus BioSciences, Inc. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  5. US 9789185

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  6. US 9782480

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  7. US 9782479

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  8. US 9770510

    Etanercept formulations stabilized with xylitol

    Coherus BioSciences, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  9. US 9770507

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  10. US 9765139

    Perfusion method for manufacturing etanercept

    Coherus BioSciences, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  11. US 9757454

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  12. US 9737600

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  13. US 9731008

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  14. US 9731009

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  15. US 9724414

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  16. US 9724415

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  17. US 9707293

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  18. US 9682145

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  19. US 9662396

    Stable aqueous formulations of etanercept

    Coherus BioSciences, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  20. US 9393305

    Etanercept formulations stabilized with xylitol

    Coherus BioSciences, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  21. US 9382317

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted
  22. US 9346880

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted May 24, 2016 · Expires May 19, 2036

    granted
  23. US 9340611

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  24. US 9340612

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted